1-225404451-T-C
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM5PP3_StrongPP5_Very_Strong
The NM_002296.4(LBR):āc.1640A>Gā(p.Asn547Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000378 in 1,614,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N547D) has been classified as Likely pathogenic.
Frequency
Consequence
NM_002296.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LBR | NM_002296.4 | c.1640A>G | p.Asn547Ser | missense_variant | 13/14 | ENST00000272163.9 | NP_002287.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LBR | ENST00000272163.9 | c.1640A>G | p.Asn547Ser | missense_variant | 13/14 | 1 | NM_002296.4 | ENSP00000272163.4 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251478Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135912
GnomAD4 exome AF: 0.0000376 AC: 55AN: 1461832Hom.: 0 Cov.: 31 AF XY: 0.0000385 AC XY: 28AN XY: 727214
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74350
ClinVar
Submissions by phenotype
LBR-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 04, 2023 | The LBR c.1640A>G variant is predicted to result in the amino acid substitution p.Asn547Ser. This variant has been reported in the compound heterozygous state with a nonsense variant (p.Arg76*) in an individual with rhizomelic skeletal dysplasia with Pelger-Huet anomaly (Sobreira et al. 2015. PubMed ID: 25348816). An alternate nucleotide change affecting the same amino acid (p.Asn547Asp) was reported in the homozygous state in a fetus with features consistent with Greenberg skeletal dysplasia (Konstantinidou et al. 2008. PubMed ID: 18382993). The p.Asn547 amino acid is located within a transmembrane region in the sterol reductase domain of the Lamin B Receptor, and maps to the NADPH binding pocket (Turner. 2016. PubMed ID: 27830109). The p.Asn547Asp substitution was reported to reduce NADPH binding capacity by nearly 12-fold and lead to a near complete loss of de novo cholesterol synthesis, emphasizing the importance of the p.Asn547 amino acid (Turner. 2016. PubMed ID: 27830109). This variant is reported in 0.0080% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/1-225592153-T-C). Taken together, the p.Asn547Ser variant is interpreted as likely pathogenic. - |
Anadysplasia-like, spontaneously remitting spondylometaphyseal dysplasia Pathogenic:1
Pathogenic, criteria provided, single submitter | research | Baylor-Hopkins Center for Mendelian Genomics, Johns Hopkins University School of Medicine | - | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 20, 2023 | This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 547 of the LBR protein (p.Asn547Ser). This variant is present in population databases (rs374343844, gnomAD 0.008%). This missense change has been observed in individual(s) with clinical features of LBR-related skeletal condition (PMID: 25348816; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 224875). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LBR protein function with a positive predictive value of 80%. This variant disrupts the p.Asn547 amino acid residue in LBR. Other variant(s) that disrupt this residue have been observed in individuals with LBR-related conditions (PMID: 18382993), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. - |
RHIZOMELIC SKELETAL DYSPLASIA WITH PELGER-HUET ANOMALY Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 17, 2022 | - - |
Greenberg dysplasia Pathogenic:1
Pathogenic, criteria provided, single submitter | research | Baylor-Hopkins Center for Mendelian Genomics, Johns Hopkins University School of Medicine | - | - - |
Reynolds syndrome Uncertain:1
Uncertain significance, flagged submission | clinical testing | Baylor Genetics | Jul 09, 2019 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at